Stock SGMO SANGAMO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Sangamo Therapeutics, Inc.

Equities

SGMO

US8006771062

Market Closed - Nasdaq
Other stock markets
 01:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
0.522 USD -4.01% Intraday chart for Sangamo Therapeutics, Inc. +3.78% -3.92%
22/03 Sangamo Therapeutics Prices $24 Million Registered Direct Offering MT
14/03 Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says MT

Chart calendar Sangamo Therapeutics, Inc.

a84e187772ce5854e5ac653.lvCYWPnUQeQOe5w-74yyAH1x-WczKhQUpLOdQk6Y8rM.oML5IKaTEottDN1c1t31TBA1yRB-QF1cyMHSLyzPmYfan88ivK0SiFFNzQ~d42431c765d6426d99c92717e1539913

Upcoming events on Sangamo Therapeutics, Inc.

09/05/2024 01:30 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 117
09/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 637
09/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 722
09/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 547
09/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 642
09/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 636
10/05/2024 01:30 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 192
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 985
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1052
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1032
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1121
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1120
10/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1126
11/05/2024 02:45 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 351
11/05/2024 03:00 am American Society of Gene & Cell Therapy Meeting - Abstract Number - 1680

Past events on Sangamo Therapeutics, Inc.

01/05/2024 Q1 2024 Earnings Release (Projected)
14/03/2024 02:00 am Q4 2023 Earnings Call
13/03/2024 05:31 pm Q4 2023 Earnings Release
09/02/2024 04:30 am World Symposium - Poster: 145
09/02/2024 04:30 am World Symposium - Poster: 048
08/02/2024 04:30 am World Symposium - Poster #145
11/12/2023 American Society for Hematology and Exposition Meeting
15/11/2023 02:30 pm Jefferies London Healthcare Conference
08/11/2023 Truist Securities Healthcare Conference
02/11/2023 06:00 pm Q3 2023 Earnings Call
02/11/2023 01:31 am Q3 2023 Earnings Release
25/10/2023 09:45 pm European Society of Gene Cell Therapy Congress - Abstract No: P212
25/10/2023 08:30 pm European Society of Gene Cell Therapy Congress - Abstract No: P487
25/10/2023 08:30 pm European Society of Gene Cell Therapy Congress - Abstract No: P475
25/10/2023 08:30 pm European Society of Gene and Cell Therapy Conference - Abstract No: P415
25/10/2023 08:30 pm European Society of Gene and Cell Therapy Conference - Abstract No: P503
24/10/2023 08:30 pm European Society of Gene and Cell Therapy Conference - Abstract No: OR09
27/09/2023 08:30 pm Jefferies Cell & Genetic Medicine Summit
07/09/2023 01:15 am Wells Fargo Healthcare Conference
09/08/2023 02:00 am Q2 2023 Earnings Call

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		102
63,3
61.9%		118
124
-4.51%		111
110
0.62%		111
111
0.51%		176
182
-3.3%
36,9

EBITDA
Million USD		Released
Forecast
Spread 		-101
-146
30.43%		-124
-118
-5.34%		-174
-188
7.34%		-189
-197
4.09%		-104
-247
57.92%
-108

EBIT
Million USD		Released
Forecast
Spread 		-105
-145
27.6%		-130
-115
-12.2%		-183
-196
6.28%		-201
-206
2.18%		-274
-241
-13.8%
-117

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-95,4
-137
30.25%		-121
-107
-13.01%		-178
-191
7%		-192
-198
3.33%		-263
-250
-4.97%
-109

Net income
Million USD		Released
Forecast
Spread 		-95,2
-137
30.65%		-121
-108
-12.47%		-178
-191
6.41%		-192
-199
3.44%		-258
-245
-5.13%
-109

EPS
USD		Released
Forecast
Spread 		-0,85
-1,24
31.31%		-0,90
-0,82
-9.93%		-1,23
-1,33
7.24%		-1,25
-1,30
3.7%		-1,48
-1,38
-6.88%
-0,50

Announcement Date28/02/2024/02/2124/02/2222/02/2313/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		28,0
27,4
2.27%		28,2
27,3
3.46%		29,4
24,6
19.28%		26,5
26,8
-1.22%		27,2
26,9
1.39%		158
106
49.21%		6,84
15,3
-55.42%		9,40
10,4
-9.67%		2,04
8,11
-74.81%
6,36


7,72


7,16


17,4


12,0

EBITDA
Million USD		Released
Forecast
Spread 		-37,1
-50,9
27.11%		-42,4
-59,5
28.69%		-42,9
-52,5
18.38%		-51,8
-43,5
-19.18%		-52,0
-58,0
10.26%		80,1
24,8
222.96%		-68,0
-60,2
-12.91%		-56,1
-70,9
20.85%		-59,9
-54,1
-10.79%
-45,5


-34,5


-34,6


20,3




EBIT
Million USD		Released
Forecast
Spread 		-39,9
-52,4
23.91%		-45,3
-47,8
5.34%		-45,7
-53,6
14.68%		-54,9
-53,0
-3.6%		-55,4
-59,7
7.27%		76,6
-29,1
362.86%		-72,2
-58,6
-23.22%		-61,6
-58,0
-6.19%		-62,1
-48,2
-28.73%
-40,3


-32,0


-29,1


-15,3


-21,0

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-37,6
-51,1
26.49%		-43,9
-46,8
6.09%		-43,1
-52,7
18.21%		-53,1
-51,6
-3.05%		-51,7
-58,0
10.89%		21,3
-28,0
176.17%		-121
-56,4
-114.2%		-103
-57,8
-78.06%		-60,6
-47,8
-26.63%
-38,3


-30,1


-27,5


-13,4


-18,0

Net income
Million USD		Released
Forecast
Spread 		-37,5
-50,9
26.39%		-44,0
-46,8
6.07%		-43,2
-52,5
17.69%		-53,2
-51,5
-3.22%		-52,0
-58,4
10.95%		21,1
-28,4
174.29%		-115
-57,3
-99.91%		-104
-57,8
-80.26%		-60,3
-47,8
-26.06%
-38,3


-30,1


-27,5


-13,4


-18,0

EPS
USD		Released
Forecast
Spread 		-0,26
-0,35
25.07%		-0,30
-0,31
4.59%		-0,29
-0,36
18.31%		-0,34
-0,36
4.76%		-0,32
-0,36
10.61%		0,12
-0,19
162.43%		-0,66
-0,34
-97.01%		-0,59
-0,33
-81.23%		-0,34
-0,26
-32.7%
-0,22


-0,15


-0,13


-0,07


-0,08

Announcement Date24/02/2205/05/2204/08/2203/11/2222/02/2308/05/2308/08/2301/11/2313/03/24-----

Upcoming sector events for Sangamo Therapeutics, Inc.

06/05/2024 FRAZIER LIFESCIENCES ACQUISITION CORPORATION: Q1 2024 Earnings Release (Projected)
06/05/2024 KRYSTAL BIOTECH, INC.: Q1 2024 Earnings Release
06/05/2024 MERUS N.V.: Q1 2024 Earnings Release (Projected)
06/05/2024 VAXCYTE, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 INHIBRX, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024 BIONTECH SE: Q1 2024 Earnings Release
06/05/2024 04:30 pm BIOCRYST PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
07/05/2024 01:31 am VERTEX PHARMACEUTICALS INCORPORATED: Q1 2024 Earnings Release
07/05/2024 COGENT BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
07/05/2024 LONGBOARD PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Sangamo Therapeutics, Inc.

03/05/2024 01:31 am ASCENDIS PHARMA A/S: Q1 2024 Earnings Release
02/05/2024 08:30 pm GENMAB A/S: Q1 2024 Earnings Release
02/05/2024 04:30 pm AGIOS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 04:00 pm SPRINGWORKS THERAPEUTICS, INC.: Q1 2024 Earnings Release
02/05/2024 04:00 pm REGENERON PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
02/05/2024 03:30 pm AURINIA PHARMACEUTICALS INC.: Q1 2024 Earnings Release
02/05/2024 ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
02/05/2024 GERON CORPORATION: Q1 2024 Earnings Release
02/05/2024 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. SGMO Stock
  4. Calendar Sangamo Therapeutics, Inc.